Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 28 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Buy checklist
History depth
Watch
3.3 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -17.3%. Ask whether you can hold through a similar fall.
Vs category
Fail
2% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 99.7% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
18 Feb 2026 – open
Trough 31 Mar 2026 · not recovered
-17.3%
26 Sept 2024 – 21 Apr 2025
Trough 27 Jan 2025 · recovered in 84 days
-13.3%
15 Dec 2023 – 3 Jun 2024
Trough 12 Feb 2024 · recovered in 112 days
-9.7%
27 Jun 2025 – 20 Oct 2025
Trough 29 Aug 2025 · recovered in 52 days
-8.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
45
Vs category
53
Consistency
27
Risk-adjusted
25
Drawdown
57
Mean
41
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
No supporting reads in the current evidence set.
31 Aug 2026 · 12 holdings · top 10 are 99.7%.
Asset mix
Equity
99.7%
Cash
0.3%
Sectors
Financial
100.0%
DECISION
Status moved from HEALTHY to MONITOR.
27 Oct 2026
DECISION
Status moved from MONITOR to HEALTHY.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
DECISION
Status moved from HEALTHY to MONITOR.
22 Sept 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Edelweiss Mutual Fund
Aditya Birla Sun Life Mutual Fund
Caveat: Lower trailing returns
Aditya Birla Sun Life Mutual Fund
Caveat: Lower trailing returns
Angel One Mutual Fund
Caveat: Lower trailing returns
DSP Mutual Fund
Caveat: Deeper drawdown
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 28 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Buy checklist
History depth
Watch
3.3 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -17.3%. Ask whether you can hold through a similar fall.
Vs category
Fail
2% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 99.7% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
NAV
28 Oct 2026 · -5.6% over 1Y
27.1792
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
28 Oct 2026
-8.0%
18 Feb 2026 – open
Trough 31 Mar 2026 · not recovered
-17.3%
26 Sept 2024 – 21 Apr 2025
Trough 27 Jan 2025 · recovered in 84 days
-13.3%
15 Dec 2023 – 3 Jun 2024
Trough 12 Feb 2024 · recovered in 112 days
-9.7%
27 Jun 2025 – 20 Oct 2025
Trough 29 Aug 2025 · recovered in 52 days
-8.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
45
Vs category
53
Consistency
27
Risk-adjusted
25
Drawdown
57
Mean
41
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
No supporting reads in the current evidence set.
31 Aug 2026 · 12 holdings · top 10 are 99.7%.
Asset mix
Equity
99.7%
Cash
0.3%
Sectors
Financial
100.0%
DECISION
Status moved from HEALTHY to MONITOR.
27 Oct 2026
DECISION
Status moved from MONITOR to HEALTHY.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
DECISION
Status moved from HEALTHY to MONITOR.
22 Sept 2026